Literature DB >> 31775079

Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.

Jennifer L Syvertsen1, Robin A Pollini2.   

Abstract

BACKGROUND: Sterile syringe access reduces injection-related health harms, yet access in the U.S. remains grossly inadequate. In California, syringe services programs (SSPs) are authorized mainly at the local level, and many communities remain underserved. State law also allows, but does not require, non-prescription syringe sales at pharmacies, but participation is low. We draw on the theoretical concept of "landscapes of antagonism" to examine how discordance between state and local decision-making contributes to uneven syringe access and health harms in California's Central Valley, where injection rates are high.
METHODS: Our study took place in Fresno and Kern counties. We draw on participant observation and qualitative interviews with individuals who inject drugs and key informants to examine issues around syringe access.
RESULTS: Overall, 8 key informants represented harm reduction, medical, and faith-based organizations. Among 46 people who inject drugs, mean age was 39 (range: 20-65), 37% were female, and 37% self-identified as Latino. About half of individuals at each site had ever successfully purchased from pharmacies, but limited locations and perceived judgement from pharmacy staff posed common barriers. There was no SSP in Kern County due to political opposition; Fresno's SSP has been run by volunteers for more than 20 years despite opposition, and recently gained authorization. Reflecting this disparity, all but two individuals in Fresno accessed syringes from the SSP, whereas only one person in Kern had ever been to an SSP. To fill gaps in access in both sites, individuals obtained syringes that were often already used from diabetics, friends, and people on the street, sharing and reusing syringes at dangerously high rates.
CONCLUSION: Landscapes of antagonism create syringe access inequities that threaten to exacerbate disease transmission and other health harms. Our study raises questions about accountability for the health of people who use drugs and suggests a need for political action.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  California; Injection drug use; Landscapes of antagonism; Nonprescription pharmacy syringe sales; Syringe access; Syringe services programs

Mesh:

Year:  2019        PMID: 31775079      PMCID: PMC7001150          DOI: 10.1016/j.drugpo.2019.10.018

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  33 in total

1.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

2.  Ideological Anachronism Involving Needle and Syringe Exchange Programs: Lessons From the Indiana HIV Outbreak.

Authors:  Josiah D Rich; Eli Y Adashi
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

3.  Access to sterile syringes for injecting drug users in New York City: politics and perception (1984-2010).

Authors:  Daliah Heller; Denise Paone
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

4.  Wild . . . But Not So Wonderful-Responding to Injection Drug Use in West Virginia.

Authors:  Robin A Pollini
Journal:  Am J Public Health       Date:  2019-03       Impact factor: 9.308

5.  Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.

Authors:  Cyprian Wejnert; Kristen L Hess; H Irene Hall; Michelle Van Handel; Demorah Hayes; Paul Fulton; Qian An; Linda J Koenig; Joseph Prejean; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-02       Impact factor: 17.586

Review 6.  Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.

Authors:  Catherine E Paquette; Robin A Pollini
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

7.  Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico.

Authors:  Peter J Davidson; Remedios Lozada; Perth C Rosen; Armando Macias; Manuel Gallardo; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2012-06-05

8.  Nonprescription syringe sales: Resistant pharmacists' attitudes and practices.

Authors:  Elizabeth Chiarello
Journal:  Drug Alcohol Depend       Date:  2016-06-27       Impact factor: 4.492

Review 9.  Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.

Authors:  Ricardo M Fernandes; Maria Cary; Gonçalo Duarte; Gonçalo Jesus; Joana Alarcão; Carla Torre; Suzete Costa; João Costa; António Vaz Carneiro
Journal:  BMC Public Health       Date:  2017-04-11       Impact factor: 3.295

Review 10.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Authors:  Esther J Aspinall; Dhanya Nambiar; David J Goldberg; Matthew Hickman; Amanda Weir; Eva Van Velzen; Norah Palmateer; Joseph S Doyle; Margaret E Hellard; Sharon J Hutchinson
Journal:  Int J Epidemiol       Date:  2013-12-27       Impact factor: 7.196

View more
  2 in total

1.  Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.

Authors:  E Childs; K B Biello; P K Valente; P Salhaney; D L Biancarelli; J Olson; J J Earlywine; B D L Marshall; A R Bazzi
Journal:  Int J Drug Policy       Date:  2020-12-16

2.  Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley.

Authors:  Joseph Friedman; Jennifer L Syvertsen; Philippe Bourgois; Alex Bui; Leo Beletsky; Robin Pollini
Journal:  Int J Drug Policy       Date:  2020-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.